-
公开(公告)号:EP3806962A1
公开(公告)日:2021-04-21
申请号:EP19737325.1
申请日:2019-06-12
申请人: Novartis AG
发明人: ABUJOUB, Aida , FLEMING, Tony , HUANG, Lu , HONG, Connie , BLANKENSHIP, John , HOLMBERG, Brian , ZHANG, Chonghui , BU, Dexiu
-
公开(公告)号:EP4065158A2
公开(公告)日:2022-10-05
申请号:EP20829415.7
申请日:2020-11-25
申请人: Novartis AG
发明人: ABUJOUB, Aida , BLANKENSHIP, John , BONDANZA, Attilio , BROGDON, Jennifer , BU, Dexiu , DE VITA, Serena , DRANOFF, Glenn , ENGELS, Boris , FLEMING, Tony , GREENE, Michael, R. , HACK, Anniesha , HOLMBERG, Brian , HONG, Connie , HUANG, Lu , KODRASI, Olja , LIM, Hyungwook , PRATICO, Elizabeth, Dorothy , PRICE, Andrew , SOHONI, Akash , STEIN, Andrew, Marc , TREANOR, Louise , ZHANG, Chonghui , GRANDA, Brian, Walter , LAM, Joni, Waiee , GUIMARAES, Carla, Patricia , ZHU, Xu
IPC分类号: A61K39/00 , C07K14/705 , C07K16/28 , A61P35/00
-
公开(公告)号:EP3844267A2
公开(公告)日:2021-07-07
申请号:EP19779634.5
申请日:2019-08-30
申请人: Novartis AG
发明人: TREANOR, Louise , GREENE, Michael R. , BROGDON, Jennifer , ENGELS, Boris , DRANOFF, Glenn , KODRASI, Olja , LIM, Hyungwook , SOHONI, Akash , PRATICO, Elizabeth Dorothy , HACK, Anniesha , ABUJOUB, Aida , FLEMING, Tony , HUANG, Lu , HONG, Connie , BLANKENSHIP, John , HOLMBERG, Brian , ZHANG, Chonghui , BU, Dexiu , PRICE, Andrew , ZHU, Xu , STEIN, Andrew , BONDANZA, Attilio
IPC分类号: C12N5/0783 , A61K35/17 , G01N33/569 , A61K35/12 , C07K14/725
-
4.LECTIN-LIKE OXIDIZED LDL RECEPTOR1 ANTIBODIES AND METHODS OF USE 审中-公开
标题翻译: LEKTINÄHNLICHEOXIDIERTE LDL-REZEPTOR1-ANTIKÖRPERUND VERFAHREN ZUR VERWENDUNG公开(公告)号:EP3010937A2
公开(公告)日:2016-04-27
申请号:EP14742016.0
申请日:2014-06-20
申请人: Novartis AG
发明人: HELDWEIN, Kurt Alex , SPLAWSKI, Igor , BROGDON, Jennifer , GOLDSTEIN, Joshua , DOLE, William , TRAUGER, John , ZHANG, Chonghui
IPC分类号: C07K16/28
CPC分类号: C07K16/28 , A61K9/0019 , A61K39/3955 , A61K45/06 , A61K2039/505 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , C07K14/4726 , C07K16/2851 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要: The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same.
摘要翻译: 本发明涉及结合人凝集素样氧化型低密度脂蛋白(LDL)(低密度脂蛋白)受体1(以下有时称为“LOX-1”)的单克隆抗体,以及包含其的药物组合物和治疗方法。
-
-
-